2017
DOI: 10.1016/j.jval.2017.08.558
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: In this study, the direct medical cost of UC treatment in Japan was estimated. As the UC is a lifelong disease that appears mainly in young adults, the economic impact including productivity loss is expected to be even greater.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A recent US study reported that patients with UC incurred USD 10,304 more in direct healthcare costs per patient per year compared to matched controls without an IBD diagnosis [ 6 ]. In Japan, the estimated annual medical cost of UC was approximately USD 249 million and annual per patient cost was USD 1,457 (1 USD = 110 JPY) in the assessment financial year 2014–2015 [ 7 ]. Although the majority of this burden is attributed to the direct costs of treatment [ 6 ], inappropriate treatment, lack of treatment adherence, or suboptimal treatment may also increase the economic burden [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…A recent US study reported that patients with UC incurred USD 10,304 more in direct healthcare costs per patient per year compared to matched controls without an IBD diagnosis [ 6 ]. In Japan, the estimated annual medical cost of UC was approximately USD 249 million and annual per patient cost was USD 1,457 (1 USD = 110 JPY) in the assessment financial year 2014–2015 [ 7 ]. Although the majority of this burden is attributed to the direct costs of treatment [ 6 ], inappropriate treatment, lack of treatment adherence, or suboptimal treatment may also increase the economic burden [ 8 ].…”
Section: Introductionmentioning
confidence: 99%